EHR

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Patent supports AIM’s strategy to expand international market protection, providing opportunities for licensing, collaborations, and long-term revenue growth Japan is...

Commure Partners with Bethany Children’s Health Center to Help Reduce Clinician Documentation Burden and Enhance Productivity

Robust healthcare platform to streamline workflows across inpatient and outpatient settingsMOUNTAIN VIEW, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Commure,...

MindHYVE.ai™ Unveils ChironAI™: The World’s First AGI-Powered Clinical Decision Support System, Redefining Healthcare Intelligence

NEWPORT BEACH, Calif., Sept. 24, 2025 /PRNewswire/ -- HYVE Labs™ and MindHYVE.ai™ proudly announce the global launch of ChironAI™, an...

Nira Medical and Rocky Mountain MS Clinic to Present First of Its Kind AI-Powered Multiple Sclerosis Registry at ECTRIMS 2025

Integrating Century Health's novel large language model (LLM) with electronic health records (EHRs) rapidly delivered 130k+ clinical variables to advance...

IgniteData Selected for Microsoft for Startups Pegasus Program: Agentic AI Powers Archer Solution to Transform Clinical Trial Data Transfer

NEW CASTLE, Del., Sept. 24, 2025 /PRNewswire/ -- IgniteData, the healthtech company behind Archer—an advanced EHR-to-EDC solution delivering fully automated, regulatory-grade...

A Historic Leap Toward Curing Heart Disease: New Study Shows Cavadex Dramatically Reverses Symptoms and Restores Quality of Life in High-Risk Patients

Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's...

A Historic Leap Toward Curing Heart Disease: New Study Shows Cavadex Dramatically Reverses Symptoms and Restores Quality of Life in High-Risk Patients

Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's...

New Novartis data further support benefits of Kesimpta® in relapsing MS following switch from oral disease modifying therapies

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis...

Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients

WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical...

QuickTake Health Joins CMS “Make Health Tech Great Again” Initiative to Eliminate Paper Intake Forms and Modernize Provider Documentation Workflow

NEW ORLEANS, Sept. 23, 2025 /PRNewswire/ -- QuickTake Health has announced its commitment to the Centers for Medicare & Medicaid Services...

error: Content is protected !!